Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 900 of 3173 entries
View as:

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

Phase: N/A Priority: Normal
NCT ID: NCT00856544 Org: User:
Start: 05/31/09 End: 01/31/11 Due: 01/31/12

A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01707082 Org: User:
Start: 10/31/12 End: 05/31/13 Due: 05/31/14

Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01812265 Org: User:
Start: 06/30/13 End: 08/31/13 Due: 08/31/14

A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00999518 Org: User:
Start: 01/22/10 End: 01/21/11 Due: 01/21/12

A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03210961 Org: User:
Start: 07/14/17 End: 01/25/19 Due: 01/25/20

Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT02206607 Org: User:
Start: 09/30/14 End: 01/31/15 Due: 01/31/16

A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin

Phase: N/A Priority: Normal
NCT ID: NCT00774605 Org: User:
Start: 12/31/08 End: 12/31/08 Due: 12/31/09

A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection

Phase: N/A Priority: Normal
NCT ID: NCT01473836 Org: User:
Start: 11/30/11 End: 10/31/12 Due: 10/31/13

Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Phase: N/A Priority: Normal
NCT ID: NCT00871494 Org: User:
Start: 05/31/09 End: 11/30/10 Due: 11/30/11

A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.

Phase: N/A Priority: Normal
NCT ID: NCT04866225 Org: User:
Start: 05/11/21 End: 08/06/21 Due: 08/06/22

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00139698 Org: User:
Start: 09/30/05 End: 07/31/06 Due: 07/31/07

Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00555620 Org: User:
Start: 05/31/08 End: 12/31/11 Due: 12/31/12

A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06103734 Org: User:
Start: 09/15/25 End: 08/02/27 Due: 08/02/28

A Study to Learn More About Tukysa Once it is Out in the Korean Market

Phase: N/A Priority: Normal
NCT ID: NCT06873191 Org: User:
Start: 12/01/26 End: 06/30/30 Due: 06/30/31

A Comparison Of The Pharmacokinetics Of PF-04191834 Following Single Dose Administration Of A Dispersion Formulation And A Suspension Formulation In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01265732 Org: User:
Start: 12/31/10 End: 01/31/11 Due: 01/31/12

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT01204853 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00488995 Org: User:
Start: 07/31/07 End: - Due: -

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

Phase: N/A Priority: Normal
NCT ID: NCT06130410 Org: User:
Start: 03/06/24 End: 07/26/24 Due: 07/26/25

A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS

Phase: N/A Priority: Normal
NCT ID: NCT03827668 Org: User:
Start: 02/07/19 End: 04/29/19 Due: 04/29/20

Open-Label Extension and Safety Study of Talazoparib

Phase: N/A Priority: Normal
NCT ID: NCT02921919 Org: User:
Start: 11/08/16 End: 07/20/21 Due: 07/20/22

Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02097433 Org: User:
Start: 07/31/14 End: 09/30/14 Due: 09/30/15

Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00594204 Org: User:
Start: 04/30/08 End: 08/31/09 Due: 08/31/10

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT05905341 Org: User:
Start: 01/15/24 End: 04/13/28 Due: 04/13/29

Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00424333 Org: User:
Start: 05/31/99 End: 10/31/00 Due: 10/31/01

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04427917 Org: User:
Start: 11/24/20 End: 03/31/21 Due: 03/31/22